Vladimir A. Mitkevich
St. Petersburg Branch
Saint Petersburg, SPE, Russian Federation
Saint Petersburg, SPE, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Fast nanoDSF Tear Fluid Profiling: Toward Diagnosis of Age-Related Macular Degeneration.
Journal: Life (Basel, Switzerland)
Published: April 27, 2026
Peripheral Administration of isoD7-Aβ Exacerbates Motor Deficits and Tau Pathology in P301S Mice.
Journal: Frontiers in bioscience (Landmark edition)
Published: April 24, 2026
Is amyloid beta peptide a driver of inflammaging?
Journal: Ageing research reviews
Published: March 22, 2026
Beta-Amyloid Suppresses Mitochondrial ATP Production in Human Neuroblastoma Cells.
Journal: Biochemistry. Biokhimiia
Published: March 17, 2026
Plasma Protein Panel for Assessing the Risk of Alzheimer's Disease by MRM-MS Analysis: The Study of Two Independent Clinical Cohorts.
Journal: International journal of molecular sciences
Published: November 06, 2025
An Optimized Protocol for Enzymatic Hypothiocyanous Acid Synthesis.
Journal: Methods and protocols
Published: November 03, 2025
The Tetrapeptide HAEE Promotes Amyloid-Beta Clearance from the Brain.
Journal: International journal of molecular sciences
Published: October 21, 2025
Impact of the diverse cardiotonic steroids on beta-amyloid precursor protein level.
Journal: Frontiers in pharmacology
Published: October 12, 2025
Pathological and Functional Brain Amyloids: A New Concept Explaining the Differences.
Journal: International journal of molecular sciences
Published: October 10, 2025
Ischaemia/reperfusion and permanent ischaemia differentially affect haemoglobin properties - Possible influence of oxidative stress and adaptation to acute hypoxia.
Journal: The FEBS journal
Published: September 30, 2025
Bifunctional BODIPY-Clioquinol Copper Chelator with Multiple Anti-AD Properties.
Journal: International journal of molecular sciences
Published: September 30, 2025
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease.
Journal: Acta naturae
Published: September 03, 2025
Last Updated: 09/26/2026